Cargando…

Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology

Parkinson’s disease (PD) is the most common neurodegenerative movement disorder without any objective biomarker available to date. Increasing evidence highlights the critical role of neuroinflammation, including T cell responses, and spreading of aggregated α-synuclein in PD progression. Lymphocyte-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelopoulou, Efthalia, Paudel, Yam Nath, Villa, Chiara, Shaikh, Mohd. Farooq, Piperi, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235703/ https://www.ncbi.nlm.nih.gov/pubmed/32340360 http://dx.doi.org/10.3390/biology9040086

Ejemplares similares

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Flotillin: A Promising Biomarker for Alzheimer’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Emerging Pathogenic and Prognostic Significance of Paired Box 3 (PAX3) Protein in Adult Gliomas
por: Angelopoulou, Efthalia, et al.
Publicado: (2019)

HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
por: Paudel, Yam Nath, et al.
Publicado: (2020)

From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders
por: Mishra, Awanish, et al.
Publicado: (2021)

Anti-High Mobility Group Box-1 Monoclonal Antibody Attenuates Seizure-Induced Cognitive Decline by Suppressing Neuroinflammation in an Adult Zebrafish Model
por: Paudel, Yam Nath, et al.
Publicado: (2021)

Can sars-cov-2 infection exacerbate Alzheimer’s disease? A systematic review
por: Chiara, Villa, et al.
Publicado: (2021)

New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders
por: Villa, Chiara, et al.
Publicado: (2022)

Recent Developments in Diagnosis of Epilepsy: Scope of MicroRNA and Technological Advancements
por: Bandopadhyay, Ritam, et al.
Publicado: (2021)

HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
por: Paudel, Yam Nath, et al.
Publicado: (2018)

Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
por: Gu, Hao, et al.
Publicado: (2021)

Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review
por: Kundap, Uday Praful, et al.
Publicado: (2020)

Embelin prevents amyloid-beta accumulation via modulation of SOD1 in a Streptozotocin-induced AD-like condition: An evidence from in vitro investigation
por: Bhuvanendran, Saatheeyavaane, et al.
Publicado: (2022)

Embelin Prevents Seizure and Associated Cognitive Impairments in a Pentylenetetrazole-Induced Kindling Zebrafish Model
por: Kundap, Uday Praful, et al.
Publicado: (2019)

Psychosis in Parkinson’s Disease: A Lesson from Genetics
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Neurodegeneration and neuroinflammation are linked, but independent of alpha‐synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease
por: Garcia, Pierre, et al.
Publicado: (2022)

Pilocarpine Induced Behavioral and Biochemical Alterations in Chronic Seizure-Like Condition in Adult Zebrafish
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Alpha-synuclein spreading in Parkinson’s disease
por: Recasens, Ariadna, et al.
Publicado: (2014)

Immunoreactivity of Muscarinic Acetylcholine M2 and Serotonin 5-HT2B Receptors, Norepinephrine Transporter and Kir Channels in a Model of Epilepsy
por: Akyuz, Enes, et al.
Publicado: (2021)

Increased ACh-Associated Immunoreactivity in Autonomic Centers in PTZ Kindling Model of Epilepsy
por: Akyüz, Enes, et al.
Publicado: (2020)

The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy
por: Longhena, Francesca, et al.
Publicado: (2017)

CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
por: Li, Yuanyuan, et al.
Publicado: (2019)

Lymphocyte Activation Gene-3 (LAG-3) Negatively Regulates Environmentally-Induced Autoimmunity
por: Jha, Vibha, et al.
Publicado: (2014)

Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis
por: Saleh, Ramy R., et al.
Publicado: (2019)

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
por: Zella, Maria Angela Samis, et al.
Publicado: (2019)

Alpha-synuclein–mediated DNA damage, STING activation, and neuroinflammation in Parkinson’s disease
por: Standaert, David G., et al.
Publicado: (2022)

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinoma
por: Gebauer, Florian, et al.
Publicado: (2020)

Migraine, Tension-Type Headache and Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches
por: Degirmenci, Yildiz, et al.
Publicado: (2023)

Role of Lymphocyte Activation Gene-3 (Lag-3) in Conventional and Regulatory T Cell Function in Allogeneic Transplantation
por: Sega, Emanuela I., et al.
Publicado: (2014)

Lymphocyte Activation Gene 3 (LAG-3) Modulates the Ability of CD4 T-cells to Be Suppressed In Vivo
por: Durham, Nicholas M., et al.
Publicado: (2014)

Prognostic Value of Lymphocyte Activation Gene-3 (LAG-3) Expression in Esophageal Squamous Cell Carcinoma
por: Zhang, Yu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n8cr1o0akcc83ft7tgs780cqh7